Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck
Clinical trial NCT00216138 · TERMINATED
Trial details
- NCT number
- NCT00216138
- Sponsor
- Hoosier Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2007-09-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.